Clinical usefulness of markers of bone degradation and formation

References

• Demers L M, Kleerekoper M. Advances in biochemical markers of bone turnover. Clin Chem 1994; 40: 1994–95
   PubMed Web of Science ®Google Scholar
• Raisz L G, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shouokri K, Smith J. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996; 81: 37–43
   PubMed Web of Science ®Google Scholar
• Bonde M, Qvist P, Flededius C, Riis B J, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995; 80: 864–8
   PubMed Web of Science ®Google Scholar
• Garnero P, Shih W J, Gineyts E, Karpf D B, Delmas P D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 79: 1693–1700
   PubMed Web of Science ®Google Scholar
• Gertz B J, Shaoe P, Hanson D A, et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Min Research 1994; 9: 135–42
   PubMed Web of Science ®Google Scholar
• Robins S P, Black D, Paterson R C, Reid D M, Duncan A, Seibel M J. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone disease. Eur J Clin Invest 1991; 21: 310–15
   PubMed Web of Science ®Google Scholar
• Garnero P, Gineyts E, Riou J P, Delmas P D. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994; 79: 780–5
   PubMed Web of Science ®Google Scholar
• Christiansen C. What should be done at the time of menopause?. Am J Med 1995; 98: 56S–59S
   PubMed Web of Science ®Google Scholar
• Prestwood K M, Pilbeam C C, Burleson J A, Woodiel F N, Delmas P D, Deftos L J, Raisz L G. The short term effects of conjugated estrogen on bone in older women. J Clin Endocrinol Metab 1994; 79: 366–71
   PubMed Web of Science ®Google Scholar
• Kushida K, Takahashi M, Kawana K, Inoue T. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects and osteoporosis patients. J Clin Endocrinol Metab 1995; 80: 2447–50
   PubMed Web of Science ®Google Scholar
• Harris S T, Gertz B J, Genant H K, et al. The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J Clin Endocrinol Metab 1993; 76: 1399–406
   PubMed Web of Science ®Google Scholar
• Kung A W, Lorentz T, Tam S C. Thyroxine suppressive therapy decreases bone mineral density in postmenopausal women. Clin Endocrinol 1993; 39: 535–40
   PubMed Web of Science ®Google Scholar
• Ongphiphadhanakul B, Jenis L G, Braverman L E, Alex S, Stein G S, Lian J B, Branan D T. Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function. Endocrin 1993; 133: 2502–7
   PubMed Web of Science ®Google Scholar
• Garnero P, Vassy V, Bertholin A, Riou J P, Delmas P D. Markers of bone turnover in hyperthyroidism and the effects of treatment. J Clin Endocrinol Metab 1994; 78: 955–9
   PubMed Web of Science ®Google Scholar
• Hanania N A, Chapman K R, Sturtridge W C, Szalai J P, Kesten S. Dose related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995; 96: 571–9
   PubMed Web of Science ®Google Scholar
• Reeve J, Loftus J, Hesp R, Ansell B M, Wright D J, Woo P M. Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids. J Rheumatol 1993; 20: 1189–95
   PubMed Web of Science ®Google Scholar
• Marshall L A, Cain D F, Dmowski W P, Chestnut C H. Urinary N-telopeptides to monitor bone resorption while on GnRH agonist therapy. Obstet Gynecol 1996; 87: 350–4
   PubMed Web of Science ®Google Scholar
• Blumsohn A, Hannon R A, Wrate R. Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol 1994; 40: 663–70
   PubMed Web of Science ®Google Scholar
• Lloyd T, Andon M B, Rollings N, et al. Calcium supplementation and bone mineral density in adolescent girls. JAMA 1993; 270: 841–5
   PubMed Web of Science ®Google Scholar
• Bollen A M, Eyre D R. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone 1994; 15: 31–4
   PubMed Web of Science ®Google Scholar
• Schlemmer A, Hassager C, Delmas P D, Christiansen C. Urinary excretion of pyridinium cross-links in health women; the long term effects of menopause and oestrogen/progesterone therapy. Clin Endocrinol. 1994; 40: 777–82
   PubMed Web of Science ®Google Scholar
• Raisz L G, Wiita B, Artis A, et al. Comparison of the effects of estrogen one and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab. 1996; 81: 37–43
   PubMed Web of Science ®Google Scholar
• Alexandersen P, Hassager C, Riis B J. The effect of menopause and hormone replacement therapy on bone alkaline phosphatase. Scand J Clin Lab Invest. 1995; 55: 571–6
   PubMed Web of Science ®Google Scholar
• Holland E F, Studd J W, Mansell J P, et al. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet. Gynecol. 1994; 83: 180–3
   Google Scholar
• Gambacciani M, Spinetti A, Taponeco F, et al. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low dose oral contraceptive preparation on bone mineral density and metabolsim. Obstet. Gynecol. 1994; 83: 392–6
   Google Scholar
• Lipton A, Demers L, Daniloff Y, et al. Increased urinary excretion of pyridinium crosslinks in cancer patients. Clin Chem. 1993; 39: 614–18
   PubMed Web of Science ®Google Scholar
• Demers L, Costa L, Chinchilli V M, Gaydos L, Curley E, Lipton A. Biochemical markers of bone turnover in patients with metastatic bone disease. Clin Chem. 1995; 41: 1489–94
   PubMed Web of Science ®Google Scholar
• Pechersotrfer M, Zimmer-Roth I, Schilling T, et al. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. J. Clin Endocrinol. Metab. 1995; 80: 97–103
   Google Scholar